Market Place
Sourcing Support
Aenova Statement on the Evolution of the CDMO Industry
07 Nov 2024 //
PRESS RELEASE
Aenova CEO Awards for outstanding value orientation
25 Oct 2024 //
PRESS RELEASE
Aenova Strengthens Development Services: Pre-Formulation Focus
04 Oct 2024 //
PRESS RELEASE
Aenova Scales Up High-Potent Medicine Development & Manufacturing
16 Sep 2024 //
PRESS RELEASE
Aenova Adds New Gummy Line at Cornu, Romania Site
04 Sep 2024 //
CONTRACT PHARMA
Aenova expands with new gummy line for pharma and food grade
28 Aug 2024 //
PRESS RELEASE
Aenova Expert: Optimising Pre-Filled Syringe Filling Process
31 Jul 2024 //
PRESS RELEASE
Aenova Annual Report 2023: Best Financial Year in Company’s History
05 Jul 2024 //
PRESS RELEASE
Aenova Taps Anne-Sophie Bonte as Chief Quality Officer
19 Apr 2024 //
CONTRACT PHARMA
Aenova and Galvita Enter Strategic Partnership
13 Jul 2023 //
CONTRACT PHARMA
Aenova Opens New Building for Highly Potent Drugs
23 Jun 2023 //
CONTRACT PHARMA
Aenova receives rating“Highest reputation: outstanding" Focus Money Germany test
20 Jun 2023 //
PRESS RELEASE
Aenova with new organizational structure supporting future strategy
15 Jun 2023 //
PRESS RELEASE
Career orientation fair in Regensburg
12 Jun 2023 //
PRESS RELEASE
Efficient handling of high-potent APIs, a CDMO 8th Conference Milan 2023
12 Jun 2023 //
PRESS RELEASE
Successful recertifications at Aenova site Sisseln
31 May 2023 //
PRESS RELEASE
Peter Waller appointed as new CFO of Aenova
17 May 2023 //
PRESS RELEASE
Enabling innovation: challenges in solid dosage forms drug devp services
05 May 2023 //
PRESS RELEASE
CEO Jan Kengelbach about Trends in CDMO Market Interview in GBR
27 Apr 2023 //
PRESS RELEASE
Aenova receives silver medal in EcoVadis sustainability rating
06 Apr 2023 //
PRESS RELEASE
Aenova Names Roel de Nobel Head of Business Unit Solids
23 Mar 2023 //
CONTRACT PHARMA
Aenova Unveils New Sterile Strategy
10 Mar 2023 //
CONTRACT PHARMA
New Managing Director at Aenova site in Marburg, Germany
01 Mar 2023 //
PRESS RELEASE
Aenova successfully expands capsule filling capacity
11 Jan 2023 //
PRESS RELEASE
Aenova expands portfolio with innovative technologies
31 Aug 2022 //
AENOVA-GROUP
The Aenova Group publishes Annual Report 2021
29 Jul 2022 //
PRESS RELEASE
Neil Jones is appointed as the new Chief Commercial Officer of Aenova Group
29 Jul 2022 //
PRESS RELEASE
Aenova wins ifm/GIB Supply Chain Management Award
15 Jul 2022 //
PRESS RELEASE
Holistic sustainability strategy at Aenova: the CO2-free Sisseln site
30 Jun 2022 //
PRESS RELEASE
Aenova signs "Diversity Charter"
03 Jun 2022 //
PRESS RELEASE
Aenova´s Innovation Approach: Interview with CEO Jan Kengelbach in US Life
20 May 2022 //
PRESS RELEASE
Apprenticeship at Aenova
17 May 2022 //
PRESS RELEASE
Aenova achieves silver medal in EcoVadis sustainability rating
10 May 2022 //
PRESS RELEASE
Interview with Actif´s Magazine: How Aenova develops vegan softgel capsules
03 May 2022 //
PRESS RELEASE
Aenova invests in new building for the production of highly potent drugs
08 Apr 2022 //
PRESS RELEASE
Aenova strengthens HR with Tim Bauer as Senior Vice President Corporate HR
31 Mar 2022 //
PRESS RELEASE
Aenova site Kirchberg in Switzerland introduces comprehensive ISO
29 Mar 2022 //
PRESS RELEASE
Target reached! Joint Aenova donation of 100.000 € for Ukraine
23 Mar 2022 //
PRESS RELEASE
New Managing Director at the Aenova Site in Gronau
16 Mar 2022 //
PRESS RELEASE
Aenova signs "Diversity Charter"
06 Mar 2022 //
PRESS RELEASE
Aenova becomes a participant of the UN Global Compact for sustainable
11 Feb 2022 //
PRESS RELEASE
Aenova Invests in Sterile Fill/Finish Area for Vials and Prefilled Syringes
25 Oct 2021 //
CONTRACTPHARMA
Aenova Expands Capacity for Fill & Finish of Vaccines and Biologics
07 May 2021 //
CONTRACTPHARMA
Aenova Expands Sterile Production Capacity
26 Mar 2021 //
CONTRACTPHARMA
Haupt Pharma’s Generic Levonorgestrel Receives Approval In The US
06 Jul 2018 //
FDA
Haupt Pharma’s Generic Dutasteride Receives Approval In US
17 Oct 2017 //
FDA
Marine Ingredients acquires softgel production facility
15 Dec 2015 //
CPHI-ONLINE
Haupt`s Generic Levonorgestrel,Ethinyl Estradiol approved in US
13 Nov 2015 //
FDA
Haupt`s Generic Norgestimate,EthinylEstradiol approved in US
29 Oct 2015 //
FDA
